PHG Koninklijke Philips N.V.
USHealthcareAs of 2026-07-10 16:00
Why PHG matters now
Koninklijke Philips N.V. (PHG) is a US stock in Healthcare. The latest InvestLog snapshot shows $27.40 with +0.51% on the session and $26.61B in market capitalization; recent performance reads 1-month +2.80% and YTD -1.11%.
The latest financial table shown here is Q1 2026, with revenue of $3.90B, net income of $151.0M, and EPS of $0.16. Investors can compare that operating picture with valuation signals such as P/E 28.93 and FCF yield 8.4%.
The latest indexable market news headline is "Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $—. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
28.93
PEG
0.13
P/B
1.96
P/S
1.29
EV/EBITDA
10.43
DCF Value
$58.76
FCF Yield
8.4%
Div Yield
3.6%
Margins & Returns
Gross Margin
45.2%
Operating Margin
9.0%
Net Margin
5.5%
ROE
9.0%
ROA
3.6%
ROIC
5.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.90B | $151.0M | $0.16 |
| Q4 2025 | $5.10B | $395.0M | $0.41 |
| FY 2025 | $17.83B | $895.0M | $0.93 |
| Q3 2025 | $4.30B | $184.0M | $0.19 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
NL
Exchange
—
Beta
0.93
Koninklijke Philips N.V. (PHG) functions as a prominent health technology enterprise, with its operations spanning across North America and numerous international markets. The company's diverse activities are organized into three primary business divisions: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips delivers advanced diagnostic imaging solutions, which include magnetic resonance imaging (MRI), computed tomography (CT) systems, X-ray apparatus, and spectral CT technology based on detector platforms. This division also provides molecular and hybrid imaging capabilities crucial for nuclear medicine. Furthermore, it offers integrated systems for interventional procedures, along with ultrasound (echography) solutions specifically designed for diagnosis, treatment planning, and guidance in fields such as cardiology, general imaging, obstetrics/gynecology, and point-of-care applications. Complementing these are proprietary software tools for diagnostic and interventional support, alongside comprehensive enterprise diagnostic informatics products and associated services. The Connected Care division focuses on providing solutions for acute patient management, emergency care services, and specialized offerings for sleep and respiratory conditions. This also encompasses electronic medical record (EMR) systems and broader care management platforms. Meanwhile, the Personal Health segment caters to consumer well-being with products such as electric toothbrushes, replacement brush heads, interdental cleaning aids, and teeth whitening kits. It also manufactures infant feeding products and digital parental support tools, in addition to a range of male grooming and beauty products. Philips has forged significant strategic alliances, notably a collaboration with Ibex Medical Analytics Ltd. This partnership aims to jointly promote digital pathology and AI-driven solutions to hospitals, healthcare networks, and pathology laboratories worldwide. The company also maintains a key partnership agreement with NICO.LAB. Established in 1891, the company was initially known as Koninklijke Philips Electronics N.V. before officially rebranding as Koninklijke Philips N.V. in May 2013. Its corporate headquarters are located in Amsterdam, the Netherlands.